CTLA-4 regulates the murine immune response to Trypanosoma cruzi infection

被引:16
作者
Graefe, SEB [1 ]
Jacobs, T [1 ]
Wächter, U [1 ]
Bröker, BM [1 ]
Fleischer, B [1 ]
机构
[1] Bernhard Nocht Inst Trop Med, Dept Immunol, D-20359 Hamburg, Germany
关键词
CTLA-4-CD152; mice; Trypanosoma cruzi; immune suppression;
D O I
10.1111/j.0141-9838.2004.00679.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infection with Trypanosoma cruzi causes a profound suppression of T cell responsiveness to polyclonal or antigenic stimuli. In this study, we quantified expression of the negative T cell regulatory molecule CTLA-4 in T. cruzi infected mice and analysed its influence on the immune suppression. Levels of splenic CTLA-4 expression were highest around day 10 after infection, reaching 5% in resistant B6D2F1 mice, but exceeding 10% of CD4(+) T cells in C57BL/6 mice that were susceptible to mortal disease. The proliferative response of explanted splenocytes to CD3-mediated stimulation was strongly suppressed in both the susceptible and the resistant strains. Blockade of CTLA-4 in vitro with a monoclonal antibody affected neither proliferative response nor cytokine production (IFN-gamma, IL-4 and IL-2) by splenic T cells from infected C57BL/6 mice. Treatment of mice with anti-CTLA-4 antibody on the day of infection decreased IFN-gamma production and reduced mortality by about 50%. We conclude that high CTLA-4 expression is a hallmark of severe disease in murine T. cruzi infection, and that CTLA-4 has a regulative influence at the early stages during priming of the immune reaction to the parasite, augmenting a strong Th1-biased response.
引用
收藏
页码:19 / 28
页数:10
相关论文
共 59 条
[1]   Cytotoxic T-lymphocyte antigen-4 and programmed death-1 function as negative regulators of lymphocyte activation [J].
Carter, LL ;
Carreno, BM .
IMMUNOLOGIC RESEARCH, 2003, 28 (01) :49-59
[2]   HUMORAL AND CELLULAR IMMUNE-RESPONSE OF ADULTS FROM NORTHEASTERN BRAZIL WITH CHRONIC TRYPANOSOMA-CRUZI INFECTION - DEPRESSED CELLULAR IMMUNE-RESPONSE TO TRYPANOSOMA-CRUZI ANTIGEN AMONG CHAGAS-DISEASE PATIENTS WITH SYMPTOMATIC VERSUS INDETERMINATE INFECTION [J].
CETRON, MS ;
BASILIO, FP ;
MORAES, AP ;
SOUSA, AQ ;
PAES, JN ;
KAHN, SJ ;
WENER, MH ;
VANVOORHIS, WC .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1993, 49 (03) :370-382
[3]   CTLA-4-mediated inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunotherapy [J].
Chambers, CA ;
Kuhns, MS ;
Egen, JG ;
Allison, JP .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :565-594
[4]   Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor β (TGF-β) production by murine CD4+ T cells [J].
Chen, WJ ;
Jin, WW ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (10) :1849-1857
[5]  
CUNNINGHAM DS, 1980, INFECT IMMUN, V30, P496
[6]  
DOSREIS GA, 1995, PARASITOL TODAY, V11, P390
[7]   Cell-mediated immunity in experimental Trypanosoma cruzi infection [J].
DosReis, GA .
PARASITOLOGY TODAY, 1997, 13 (09) :335-342
[8]   CTLA-4: new insights into its biological function and use in tumor immunotherapy [J].
Egen, JG ;
Kuhns, MS ;
Allison, JP .
NATURE IMMUNOLOGY, 2002, 3 (07) :611-618
[9]   Uptake of apoptotic cells drives the growth of a pathogenic trypanosome in macrophages [J].
Freire-de-Lima, CG ;
Nascimento, DO ;
Soares, MBP ;
Bozza, PT ;
Castro-Faria-Neto, HC ;
de Mello, FG ;
DosReis, GA ;
Lopes, MF .
NATURE, 2000, 403 (6766) :199-203
[10]  
Gao W, 2001, EUR J IMMUNOL, V31, P1503, DOI 10.1002/1521-4141(200105)31:5&lt